Zurcher Kantonalbank (Zurich Cantonalbank) Axogen, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Axogen, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 7,901 shares of AXGN stock, worth $108,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,901Holding current value
$108,401% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding AXGN
# of Institutions
192Shares Held
39.7MCall Options Held
61.7KPut Options Held
42.8K-
First Light Asset Management, LLC Edina, MN4.47MShares$61.4 Million10.62% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$44.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$34.8 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.59MShares$21.8 Million0.54% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $580M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...